---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-075995"
form_type: "8-K"
ticker: "BCLI"
cik: "0001137883"
company_name: "BRAINSTORM CELL THERAPEUTICS INC."
filed_at: "2024-06-28T23:59:59+00:00"
generated_at: "2026-06-01T00:26:29.599746+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# BrainStorm Cell Therapeutics raises $4.0M in registered direct offering and warrants

## Summary
- Gross proceeds ~$4.0M from sale of 11.1M shares or pre-funded warrants at $0.36/share.
- Private placement of warrants to buy 16.7M shares at $0.3912, exercisable after 6 months, 5-year term.
- Existing warrants for 4.05M shares amended: exercise price cut to $0.3912, expiry extended to 2029.
- Offering expected June 28, 2024; Maxim Group as placement agent.

## SEC filing metadata
- accession: 0001104659-24-075995
- form_type: 8-K
- ticker: BCLI
- cik: 0001137883
- company_name: BRAINSTORM CELL THERAPEUTICS INC.
- filed_at: 2024-06-28T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1137883/000110465924075995/0001104659-24-075995-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1137883/000110465924075995/tm2418388d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-075995
- JSON: https://secwatch.observer/filing/0001104659-24-075995.json
- Plain text: https://secwatch.observer/filing/0001104659-24-075995.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.